Literature DB >> 14744776

Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.

Takashi Maeda1, Caroline M Alexander, Andreas Friedl.   

Abstract

Infiltrating carcinomas characteristically elicit a reactive stromal response, and accumulating evidence indicates that tumor stroma fibroblasts reciprocally promote tumor development and growth. The cell surface heparan sulfate proteoglycan, syndecan-1 (Sdc1), is thought to function as a coreceptor for growth factor and extracellular matrix interactions, and Sdc1 expression is induced in reactive stromal cells in both mice and man. Mice with a targeted mutation in Sdc1 show reduced tumor development in response to oncogene expression and altered responses to other pathological stimuli that are associated with the induction of stromal Sdc1. Here, we test the hypothesis that Sdc1 is required for the growth-promoting activities of reactive stroma. We found that when highly invasive carcinoma cells (MDA-MB-231) were placed in contact with mouse embryonic fibroblasts (MEFs) in a coculture model, Sdc1 expression was induced. Sdc1 was not induced by less invasive or normal cell lines (T47D and NMuMG). Furthermore, the growth of MDA-MB-231 cells was enhanced by 42% when cocultured with Sdc1+/+ MEFs compared with Sdc1-/- MEFs. When T47D cells were cocultured with fibroblasts that expressed transfected Sdc1, these Sdc1-positive fibroblasts stimulated growth of the breast epithelial cells by 85% compared with untransfected controls. The growth-promoting effect was completely abolished when fibroblasts were transfected with mutant Sdc1 lacking heparan sulfate attachment sites. In conclusion, we have demonstrated that a growth-promoting loop exists between breast cancer cells and their stroma that depends on the activity of glycanated Sdc1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744776     DOI: 10.1158/0008-5472.can-03-2439

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.

Authors:  Rachel K Okolicsanyi; Anne Buffiere; Jose M E Jacinto; Diego Chacon-Cortes; Suzanne K Chambers; Philippa H Youl; Larisa M Haupt; Lyn R Griffiths
Journal:  Tumour Biol       Date:  2014-11-01

Review 2.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

Review 3.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

Review 4.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

5.  Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Authors:  Matthew W Conklin; Ronald E Gangnon; Brian L Sprague; Lisa Van Gemert; John M Hampton; Kevin W Eliceiri; Jeremy S Bredfeldt; Yuming Liu; Nuntida Surachaicharn; Polly A Newcomb; Andreas Friedl; Patricia J Keely; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

6.  Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.

Authors:  Rachel K Okolicsanyi; Andre J van Wijnen; Simon M Cool; Gary S Stein; Lyn R Griffiths; Larisa M Haupt
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

7.  Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.

Authors:  Yunchao Chang; Masahiko Zuka; Pablo Perez-Pinera; Aurora Astudillo; Joanne Mortimer; James R Berenson; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 8.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

9.  Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy.

Authors:  Richard G Abramson; Lori R Arlinghaus; Jared A Weis; Xia Li; Adrienne N Dula; Eduard Y Chekmenev; Seth A Smith; Michael I Miga; Vandana G Abramson; Thomas E Yankeelov
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-10

Review 10.  Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.

Authors:  Andreas Friedl
Journal:  Semin Cell Dev Biol       Date:  2009-11-28       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.